Stock NBIX NEUROCRINE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Neurocrine Biosciences, Inc.

Equities

NBIX

US64125C1099

Real-time Estimate Cboe BZX
Other stock markets
 02:06:53 2024-05-09 pm EDT 		5-day change 1st Jan Change
140 USD +0.73% Intraday chart for Neurocrine Biosciences, Inc. +0.24% +6.38%
May. 08 Neurocrine Biosciences, Inc. Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults CI
May. 07 Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst? Program of Crinecerfont in CAH, and Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH Studies at ECE 2024 CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bullish

Bullish

Bullish

Resistance 143.74 143.74 142.15
Spread/Res.-3.28%-3.28%-2.20%
Spread/Supp.+1.04%+12.52%+18.91%
Support 137.59 123.55 116.91

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. Charts Neurocrine Biosciences, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW